Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019
- PMID: 37491566
- PMCID: PMC10592031
- DOI: 10.1111/add.16301
Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019
Abstract
Aims: To estimate the joint effects of substance use disorder (SUD) and recent substance use on human immunodeficiency virus (HIV) non-suppression.
Design: Retrospective clinical cohort study with repeated observations within individuals.
Setting: Baltimore, Maryland, United States.
Participants: 1881 patients contributed 10 794 observations.
Measurements: The primary independent variable was the combination of history of SUD and recent substance use. History of SUD was defined as any prior International Classification of Diseases 9/10 code for cocaine or opioid disorder. Recent substance use was defined as the self-report of cocaine or non-prescribed opioid use on the National Institute of Drug Abuse-modified Alcohol, Smoking and Substance Involvement Screening Test or clinician-documented cocaine or opioid use abstracted from the medical record. The outcome was viral non-suppression, defined as HIV RNA >200 copies/mL on the first viral load measurement within 1 year subsequent to each observation of substance use. We adjusted for birth sex, Black race, age, HIV acquisition risk factors, years in care and CD4 cell count. In secondary analyses, we also adjusted for depressive, anxiety and panic symptoms, cannabis use and cannabis use disorder.
Findings: On their first observation, 31% of patients had a history of an SUD and 18% had recent substance use. Relative to no history of SUD and no recent substance use, the 1-year fully adjusted risk difference (RD) for viral non-suppression associated with cocaine and opioid use disorder and recent substance use was 7.7% (95% CI = 5.3%-10.0%), the RD was 5.5% (95% CI = 1.2%-9.7%) for history of cocaine use disorder without recent substance use, and the RD was 4.6% (95% CI = 2.7%-6.5%) for recent substance use without a SUD.
Conclusions: Substance use and substance use disorders appear to be highly prevalent among, and independently associated with, viral non-suppression among people with HIV.
Keywords: cocaine use; human immunodeficiency virus; mental health; opioid use; substance use disorder; viral suppression.
© 2023 Society for the Study of Addiction.
Conflict of interest statement
Conflicts of interest: None.
Similar articles
-
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.J Clin Psychiatry. 2022 Aug 29;83(5):21m14332. doi: 10.4088/JCP.21m14332. J Clin Psychiatry. 2022. PMID: 36044600
-
Recent Substance Use and Probability of Unsuppressed HIV Viral Load Among Persons on Antiretroviral Therapy in Continuity Care.Am J Epidemiol. 2019 Oct 1;188(10):1830-1837. doi: 10.1093/aje/kwz159. Am J Epidemiol. 2019. PMID: 31360995 Free PMC article.
-
Association of Substance Use Disorders with Engagement in Care and Mortality among a Clinical Cohort of People with HIV in Washington, DC.AIDS Behav. 2021 Jul;25(7):2289-2300. doi: 10.1007/s10461-021-03157-4. Epub 2021 Feb 1. AIDS Behav. 2021. PMID: 33521909 Free PMC article.
-
Integrated care of severe infectious diseases to people with substance use disorders; a systematic review.BMC Infect Dis. 2019 Apr 4;19(1):306. doi: 10.1186/s12879-019-3918-2. BMC Infect Dis. 2019. PMID: 30947701 Free PMC article.
-
Mini review: Promotion of substance abuse in HIV patients: Biological mediation by HIV-1 Tat protein.Neurosci Lett. 2021 May 14;753:135877. doi: 10.1016/j.neulet.2021.135877. Epub 2021 Apr 7. Neurosci Lett. 2021. PMID: 33838257 Review.
Cited by
-
Supporting integration of substance use interventions in HIV service organizations: Assessing the fit of 10 strategies for AIDS Education and Training Centers to use.Implement Res Pract. 2025 Jun 19;6:26334895251343647. doi: 10.1177/26334895251343647. eCollection 2025 Jan-Dec. Implement Res Pract. 2025. PMID: 40548261 Free PMC article.
-
The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic.AIDS. 2025 Mar 15;39(4):414-423. doi: 10.1097/QAD.0000000000004074. Epub 2024 Nov 25. AIDS. 2025. PMID: 39591540
-
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support.AIDS. 2024 Dec 1;38(15):2064-2072. doi: 10.1097/QAD.0000000000003999. Epub 2024 Aug 28. AIDS. 2024. PMID: 39206880
-
Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina.AIDS. 2025 Apr 1;39(5):560-568. doi: 10.1097/QAD.0000000000004077. Epub 2024 Nov 27. AIDS. 2025. PMID: 39612232
-
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use.Addict Sci Clin Pract. 2023 Sep 2;18(1):51. doi: 10.1186/s13722-023-00408-8. Addict Sci Clin Pract. 2023. PMID: 37660116 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous